The forearms of six patients with Duchenne dystrophy were examined by the painless and non-invasive technique of high-resolution nuclear magnetic resonance spectroscopy. The phosphorus spectrum was abnormal in that the ratios of phosphocreatine to adenosine triphosphate
sequent exposure to the virus. Furthermore, more severe reactions to infection with the virus have occurred after inoculation with respiratory syncytial virus vaccine. 12 Although a recent retrospective study13 on 8-year old children showed no difference in the prevalence of atopy between 26 patients who had had acute bronchiolitis in infancy and paired controls, its findings do not compare directly with those of the present study.
In studies of the connection between acute bronchiolitis and subsequent asthma Zweiman et al '4 found retrospectively that 40-50% of children admitted to hospital because of acute bronchiolitis had recurrent wheeze subsequently and that the risk of this was higher when there was a family history of atopy or the patient showed other allergic manifestations. Bronchiolitis due to respiratory syncytial virus associated with subsequent wheezing was also found in a retrospective study by Rooney and Williams,' in which 72%/' of those with recurrent wheeze had a family history of atopy. Hyde and Saed3 found that 39% of infants less than 1 year old who presented with bronchiolitis subsequently had a recurrent wheeze and that 78% of those had a family history of atopy or allergic manifestations. Given that childhood asthma is partly an allergic condition, the fact that a high proportion of those with acute bronchiolitis (particularly those with atopic features) have subsequent episodes of wheeze supports the view that acute bronchiolitis may occur more frequently in an atopic population.
and to inorganic phosphate were reduced. Absolute quantification under the conditions of this experiment was not possible but it was probable that in dystrophy the concentration of phosphocreatine in muscle was appreciably reduced. A signal in the phosphodiester region of the spectrum was recorded consistently in patients with dystrophy but not in controls. The intracellular pH of the muscle in the dystrophic patients was abnormally alkaline.
The clinical application of nuclear magnetic resonance spectroscopy remains to be proved, but it appears to be a promising non-invasive technique for investigating biochemical abnormalities of muscle disease.
Introduction
The muscular dystrophies are characterised by progressive degeneration of muscle but not affecting the nervous system. The commonest form is Duchenne dystrophy, which is transmitted by an X-linked recessive gene. Signs of the disease usually appear within the first three years of life and are most noticeable in the legs. An initial enlargement of the muscles gives way to profound weakness and wasting, and death from inanition or cardiac or ventilatory failure occurs by the middle of the second decade.
The first biochemical defect to be discovered in the condition -namely, a decrease in urinary creatine excretion-was noted over 100 years ago. ' Since then further abnormalities have been described; and some are accepted as diagnostic criteria. Unfortunately most measurements are invasive and therefore complicated.
It is now possible to observe the energy metabolism of human muscle in vivo but non-invasively using high-resolution phosphorus nuclear magnetic resonance spectroscopy.2 This has resulted from progress in magnet technology leading to the construction of powerful magnets that can accommodate a human limb. Also the introduction of surface coils3 and field profiling4 have permitted an appreciable degree of spatial resolution.
We describe the clinical application of this technique to the study of Duchenne dystrophy.
Patients and methods
The Nevertheless, since phosphocreatine and adenosine triphosphate are subject to different degrees of magnetic saturation6 the concentration ratios of these compounds to each other were underestimated by about 30%.
Secondly, though the technique was not quantitative under the conditions of the experiment, probably both phosphocreatine and adenosine triphosphate were present in reduced amounts. If the water signal arose exclusively from muscle, division of the intensities of the phosphocreatine and adenosine triphosphate signals by the intensity of the corresponding water peak would give an index (in arbitary units) of their concentrations in muscle tissue. For phosphocreatine this value was 0 16±0 05 in the controls and 0 03±0 02 in the patients. Similarly, the control index for adenosine triphosphate of 0 07±0 03 was reduced in dystrophy to 0 02±0-01. These figures suggested a 5-5-fold reduction in the phosphocreatine concentration and a 3-5-fold reduction in adenosine triphosphate, but only if the water signal arose solely from muscle. Patients whose dystrophy is as advanced as those in this series have a large proportion of their muscle replaced by fat; this is likely to contribute appreciably to the water signal, and the values of 5-5 and 3-5 represent upper limits only. Adenosine triphosphate concentration may be unchanged in dystrophy but most probably the phosphocreatine concentration is reduced.
Thirdly, a peak was consistently identified in the patients with dystrophy that was not seen in the controls. It was recorded between the signals of inorganic phosphate and phosphocreatine and varied in position from 2-3 to 3-3 parts per million (ppm) (all peak positions quoted relative to phosphocreatine). The signal bore an intensity ratio to that of phosphocreatine of 0 3 ±0 1.
Fourthly, the position of the inorganic phosphate peak was used as an index of intracellular pH.7 In the patients this was 719±007, which differed significantly from the 7T04±0 05 in the controls (p <0.01).
Lastly, the signal from fat tissue was particularly intense in the patients, which was in keeping with the known processes of Duchenne dystrophy. PCr=Phosphocreatine. Pi Inorganic phosphate. a, P, and y refer to a-, P-, and y-phosphate groups of adenosine triphosphate. Arrow indicates additional peak seen in Duchenne dystrophy.
Discussion
In the past it has proved difficult to manufacture wide-bore magnets with sufficiently homogeneous magnetic fields and the study of dystrophic muscle by nuclear magnetic resonance spectroscopy has been restricted to examining extracts of biopsy material. 8 The spectrum of a perchloric acid extract of dystrophic chicken pectoralis contained signals from both glycerol-3-phosphorylcholine and serine ethanolamine phosphodiester, but this was not seen in the spectra of extracts of healthy chickens. Nuclear magnetic resonance examination of perchloric acid extracts of normal human quadriceps, however, showed a glycerol-3-phosphorylcholine peak that was not recorded from Duchenne muscle.
Since the nuclear magnetic resonance study of human muscle is now possible in vivo, the results are not complicated by artefacts resulting from biopsy technique, postmortem change, or chemical extraction. It is therefore interesting that a peak that varied in position in the spectrum from 2-3 to 3-3 ppm was consistently identified in the patients with Duchenne dystrophy but not in the control subjects. Signals from serine ethanolamine phosphodiester and glycerol-3-phosphorylcholine occur at 2-8 and 3-1 ppm, respectively, but in the absence of formal chemical identification we cannot conclude that these were the compounds responsible for the additional peaks seen in the patients with dystrophy.
The finding of reduced muscle concentrations of phosphocreatine and adenosine triphosphate in Duchenne dystrophy9 is no longer universally accepted, since the published figures may represent no more than a dilution of muscle by fat. This is because the reduction in adenosine triphosphate is not pronounced when observed against an internal standard such as total creatine'0 or myosin." Our findings agree with reports of a pronounced drop in the muscle phosphocreatine concentration but cannot confirm a significant reduction in adenosine triphosphate concentration.
The resting intracellular pH of the control subjects in this study was 704±005 and agreed with that of our larger control series. The pH of the patients, however, was abnormally alkaline at 7-19±0-08. To our knowledge this measurement has not been recorded before.
The abnormalities described here may have been due at least in part to the difference in age between the patients and controls. Nevertheless, several children with glycolytic enzyme deficiencies, mitochondrial myopathies, and undiagnosed muscle weakness have been examined with this technique and none has displayed the changes seen in dystrophy. We are continuing our nuclear magnetic resonance study of a wide variety of muscle diseases, and not until this has been completed can we suggest that the abnormalities presented here are diagnostic of Duchenne dystrophy.
The clinical application of nuclear magnetic resonance spectroscopy is still developmental, but none the less it holds great promise as a non-invasive technique for investigating the biochemical abnormalities underlying muscle disease.
